| Cover | Jan. 23, 2023 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jan. 23, 2023 |
| Entity File Number | 001-40356 |
| Entity Registrant Name | Rain Oncology Inc. |
| Entity Central Index Key | 0001724979 |
| Entity Tax Identification Number | 82-1130967 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 8000 Jarvis Avenue |
| Entity Address, Address Line Two | Suite 204 |
| Entity Address, City or Town | Newark |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94560 |
| City Area Code | 510 |
| Local Phone Number | 953-5559 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | RAIN |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Entity Information, Former Legal or Registered Name | Rain Therapeutics Inc. |
